34. Polio Eradication
Thursday, October 3, 2013: 10:30 AM-12:00 PM
Room: The Moscone Center: 103 (Gateway Ballroom)
Co-organized with the Center for Global Health Policy

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • explain the challenges and obstacles involved in polio eradication
  • review the vaccine needs currently and in the post-eradication era
  • describe the potential role of antiviral drugs in eradication of polio

Target Audience: public health practitioners, nurses, members-in-training, investigators, infectious diseases physicians, infectious diseases pediatricians, infection preventionists, hospital epidemiologists, hospital administrators, health care workers, fellows, epidemiologists, clinicians, academicians

Tracks: Pediatric ID, Global ID, Adult ID

Moderators:  Jay Wenger, MD, Bill & Melinda Gates Foundation and Anna Wald, MD, MPH, FIDSA, University of Washington


10:30 AM
Polio Overview
Jay Wenger, MD

11:00 AM
Vaccines Against Poliomyelitis
Walter A. Orenstein, MD, FIDSA

11:30 AM
Antiviral Drugs for Poliomyelitis
John Modlin, MD, FIDSA

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-13-083-L01-P


J. Wenger, None

A. Wald, None

W. A. Orenstein, None

J. Modlin, None

J. Wenger, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.